Some were allegedly found with their hands tied and stripped of their clothes, spokeswoman Ravina Shamdasani said
A protein-based Covid-19 vaccine made by Sinopharm, when given as a booster after two doses of an earlier shot from the Chinese firm, elicited a stronger antibody response against the Omicron variant than a third dose of the original, a study showed.
The study, which was published on Tuesday and had not been peer reviewed, came amid concerns over the effectiveness of Sinopharm's BBIBP-CorV shot, one of the two leading Covid-19 vaccines exported by China, against the Omicron variant.
An earlier study showed a BBIBP-CorV booster had weaker neutralisation against Omicron than against an older coronavirus strain from the central Chinese city of Wuhan.
Sinopharm's NVSI-06-07 protein-based vaccine, approved for emergency use as a booster in the UAE in December, adopts a different technology than the BBIBP-CorV shot that contains an inactivated form of the coronavirus.
Among 192 healthy adults vaccinated with two BBIBP-CorV doses for six months or longer, the neutralising antibody level against Omicron in those later given a NVSI-06-07 booster was "significantly higher" than that in those who received a BBIBP-CorV third dose, researchers said in a paper.
ALSO READ:
The antibody-based results are different from the efficacy readings about how well the NVSI-06-07 booster after BBIBP-CorV vaccination would protect people from Omicron-caused disease.
The authors of the paper cautioned that it remained unclear for how long the NVSI-06-07 booster's effect would last.
Some were allegedly found with their hands tied and stripped of their clothes, spokeswoman Ravina Shamdasani said
Telco’s AGM to approve cash dividends of 40 fils per share for H2 of 2023
Company showcases Hybrid Cloud Observability at GISEC 2024
Pakistan Tehreek-e-Insaf (PTI) announced a series of protests from Friday
By understanding the tactics universities employ, students can strategically craft their applications strategy
Oil demand for road transport should peak around 2025
Some of America's most prestigious universities have been rocked by protests in recent weeks as students and other agitators take over quads
Eight teams will compete in this groundbreaking event and more than 10,000 spectators are expected to witness the inaugural edition